You are here

  • Home
  • Archive
  • Volume 85, Issue Suppl 1
  • N02 Safety And Tolerability Of Selisistat For The Treatment Of Huntington’s Disease: Results From A Randomised, Double-blind, Placebo-controlled Phase Ii Trial

Citation Tools

Article menu
Download PDFPDF
Clinical therapeutics
N02 Safety And Tolerability Of Selisistat For The Treatment Of Huntington’s Disease: Results From A Randomised, Double-blind, Placebo-controlled Phase Ii Trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Reilmann R, Squitieri F, Priller J, et al
N02 Safety And Tolerability Of Selisistat For The Treatment Of Huntington’s Disease: Results From A Randomised, Double-blind, Placebo-controlled Phase Ii Trial
Journal of Neurology, Neurosurgery & Psychiatry 2014;85:A102.